gip/glp 1-agonist tirzepatide Main physiological actions of the dual GIP and GLP-1 agonist Tirzepatide Research Peptide | cGMP
Description
Why It's Unique This dual-acting option combines two pathways in one medication, giving patients a next-generation therapy under professional guidance in a convenient, accessible setting
Reach out to your healthcare team for worsening or persistent pain
Alcohol also affects digestion, hydration, sleep, blood sugar, appetite, and decision-making around food
The most common are gastrointestinal: nausea, vomiting, diarrhea, decreased appetite, and constipation
This is why Mounjaro is introduced gradually, starting with a lower dose to help reduce the intensity and duration of symptoms
